Inspire(US:INSP) Prnewswire·2025-11-21 15:05Core Viewpoint - Inspire Medical Systems is facing legal scrutiny due to allegations of misleading investors regarding the demand and launch of its Inspire V device, leading to significant financial losses for investors [3][4][5]. Group 1: Legal Investigation - Faruqi & Faruqi, LLP is investigating potential claims against Inspire Medical and has set a deadline of January 5, 2026, for investors to seek the role of lead plaintiff in a federal securities class action [1][6]. - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [2]. Group 2: Financial Impact - On August 4, 2025, Inspire Medical announced delays in the launch of the Inspire V device due to training and onboarding issues at treatment centers, as well as billing challenges with Medicare [4]. - Following the announcement of these setbacks, Inspire Medical's stock price plummeted over 32%, from $129.95 to $87.91 per share, resulting in a loss of approximately $1.2 billion in market capitalization [5]. - The company also reported weak demand and excess inventory for the Inspire V device, leading to a more than 80% cut in its 2025 earnings guidance [5].